Evanthia Galanis, MD

Professor

  • 9946 Citations
  • 48 h-Index
1976 …2021
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 23 Similar Profiles
Measles virus Medicine & Life Sciences
Oncolytic Viruses Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Glioma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Heterografts Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1976 2021

Poisoning of PARP and Topoisomerase I to Treat Ovarian Cancer

Shridhar, V., Kaufmann, S. H., Cliby, W. A., Bible, K. C., Goode, E. L., Peng, K., Galanis, E., Knutson, K. L., Hartmann, L. C., Lingle, W. L., Oberg, A. L., Couch, F. J., Fields, A. P., Haluska, P. R. J., Long, H., Bell, D., Keeney, G., Lengyel, E. & Keeney, G.

National Institutes of Health

10/1/088/31/20

Project: Research project

Ovarian Neoplasms
alvocidib
Registries
Research
Translational Medical Research
Breast Neoplasms
Research Personnel
Research
Biostatistics
Translational Medical Research
Measles virus
Measles
Glioma
Glioblastoma
Therapeutics
Measles
Ovarian Neoplasms
Measles virus
Cyclophosphamide
Neoplasms

Research Output 1996 2019

Advances in multidisciplinary therapy for meningiomas

International Consortium on Meningiomas, Jan 14 2019, In : Neuro-Oncology. 21, 1, p. i18-i31

Research output: Contribution to journalArticle

Meningioma
trabectedin
Therapeutics
Radiotherapy
Focal Adhesion Protein-Tyrosine Kinases

A key anti-viral protein, RSAD2/VIPERIN, restricts the release of Measles virus in infected cells

Kurokawa, C., Iankov, I. D. & Galanis, E., Apr 2 2019, In : Virus Research. 263, p. 145-150 6 p.

Research output: Contribution to journalArticle

Measles virus
Protein S
Viral Proteins
Methionine
Interferons

Interferon signaling predicts response to oncolytic virotherapy

Kurokawa, C. & Galanis, E., Feb 1 2019, In : Oncotarget. 10, 16, p. 1544-1545 2 p.

Research output: Contribution to journalEditorial

Oncolytic Virotherapy
Permissiveness
Measles
Interferons

Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group

Huang, R. Y., Bi, W. L., Weller, M., Kaley, T., Blakeley, J., Dunn, I., Galanis, E., Preusser, M., McDermott, M., Rogers, L., Raizer, J., Schiff, D., Soffietti, R., Tonn, J. C., Vogelbaum, M., Weber, D., Reardon, D. A. & Wen, P. Y., Jan 1 2019, In : Neuro-Oncology. 21, 1, p. 26-36 11 p.

Research output: Contribution to journalArticle

Meningioma
Clinical Trials
10 Citations (Scopus)

Adaptive global innovative learning environment for glioblastoma: GBM AGILE

GBM AGILE Network, Feb 15 2018, In : Clinical Cancer Research. 24, 4, p. 737-743 7 p.

Research output: Contribution to journalReview article

Glioblastoma
Learning
Biomarkers
Therapeutics
Random Allocation